PHAM QUANG X (CEO and Chairman) sold 0.4% of their position (652.00 shares) of CADRENAL THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/3/2026ACC: 0001213900-26-064357
DirectorOfficer10% Owner· CEO and Chairman
Since Jan 2023
-652.00
Net shares
Net seller
$3.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
652.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−303.00
Price / share
$5.01
Trade value
$1.52K
% of position
0.2%
5/29/2026
182.16K→181.86K
Common Stock
Direct
Shares
−349.00
Price / share
$4.46
Trade value
$1.56K
% of position
0.2%
6/2/2026
181.86K→181.51K
Total
Net shares
−652.00
Net value
-$3.07K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2026 | S · Sale | −303.00 | $5.01 | $1.52K | 0.2% | 182.16K | 181.86K |
| Common Stock Direct | 6/2/2026 | S · Sale | −349.00 | $4.46 | $1.56K | 0.2% | 181.86K | 181.51K |
| Total | −652.00 | -$3.07K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned200K
Total
200K indirect200K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200K | Indirect |
| Total | 200K | 200K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported